title: [Not Available].
abstract: Oligometastic progression (or solitary metastases) can justify ablative treatment for metastatic treatment. When such a strategy is discussed, it is important to notice that definition of oligometastases is not consensual both in terms of clinical presentation than on the biological basis. Does a specific biological background truly exist and are there markers that could predict for additional occult disease and its oligo or polymetastatic profile in individuals with demonstrated oligometastasis. This article provides a summary of the state of the art in this field and highlights some current areas of controversies.
authors: Service de radiothérapie, Centre Antoine Lacassagne, 33, avenue Valombrose, 06189 Nice. Electronic address: jthariat@gmail.com.
authors: Juliette
authors: J
authors: Thariat
authors: Service oncologie et hématologie, Hôpitaux de Chartres, hôpital Louis-Pasteur, 4, rue Claude Bernard, 28630 Le Coudray.
authors: Stéphane
authors: S
authors: Vignot
mesh_terms: D018450:Disease Progression; D006801:Humans; D009362:Neoplasm Metastasis / Q000235:genetics / Q000473:pathology / Q000503:physiopathology / Q000628:therapy; D010641:Phenotype
keywords: Chirurgie des métastases; Metastasectomy; Oligometastasis; Oligométastase; Oligoprogression; Radiothérapie; Stereotactic radiotherapy; stéréotaxique